UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 12, 2006
HEALTHRENU MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Nevada 000-21914 25-1907744
- --------------------------------- ------------- --------------------
(State or other jurisdiction of (Commission (IRS Employer
incorporation) File Number) Identification No.)
12777 Jones Road, Suite 481, Houston, TX 77070
---------------------------------------- -----
(Address of Principal Executive Offices) (Zip Code)
Our telephone number, including area code: (281)_890-2561
---------------
Not Applicable
-------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of us under any of the following
provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Section 8 - Other Events
Item 8.01 Other Events
As of July 12, 2006, the OTC Bulletin Board ("OTCBB") ceased quoting the
Company's shares on the OTCBB. The Company's common stock will continue to be
quoted through various market makers on the Pink Sheets Electronic Quotation
Service published by the National Quotation Bureau under the symbol "HRUM". The
Pink Sheets is a centralized quotation service that collects and publishes
market maker quotations of securities.
The Company had not timely filed with the Securities and Exchange Commission
("SEC") financial statements for the fiscal quarter ended March 31, 2006
reviewed by the Company's independent public accountant. The Company had filed
with the SEC financial statements for the fiscal quarter ended March 31, 2006
which were not reviewed by the Company's independent public accountant.
The review of the Company's financial statements for the fiscal quarter ended
March 31, 2006 was completed and the Company filed such reviewed financial
statements with the SEC on July 11, 2006 (with a filing date of July 12, 2006),
however, such filing was not made in sufficient time to prevent the OTCBB from
ceasing to quote the Company's shares. Upon such filing, the Company's stock is
again eligible for quotation on the OTCBB and the Company is pursuing
reinclusion of its share quoatations on the OTCBB.
The filing of the reviewed financial statements was delayed because the Company,
in consultation with its independent public accountant, determined in connection
with the preparation of the Company's March 31, 2006 financial statements that
the debt financings conducted by the Company during August and September 2005
and February 2006 required reevaluation as a result of evolving SEC
interpretations of the accounting rules relating to various convertible debt
instruments, which include embedded derivatives. The Company has been working
with a professional accounting firm in an effort to expedite and assist the
independent public accountant in connection with its review of these financing
transactions.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, we
have duly caused this report to be signed on our behalf by the undersigned
hereunto duly authorized.
Date: July 12, 2006
HEALTHRENU MEDICAL, INC.
(Registrant)
By: /s/ Robert W. Prokos
-------------------------------------
Name: Robert W. Prokos
Title: President and
Chief Executive Officer
3